New treatment for multiple sclerosis: Cambridge University translates research at the bench into a drug at the bedside14 November 2011
Phase III clinical trials for new MS drug very positive.
The discovery by scientists in Cambridge and Alberta of a fifth adaptor protein – a tiny and vital component of many cells –will lay the...
Seven Cambridge scientists have been appointed University Research Fellows (URFs) for 2011 by The Royal Society, the UK’s national academy of science.
The Dorothy Hodgkin Fellowship scheme supports excellent scientists and engineers at an early stage of their career.